With reference to the local conformation of a protein, it is interesting to differentiate the individual fluorescence properties of included tryptophan residues without modification. The fluorescence spectrum of bitter gourd trypsin inhibitor (BGTI) was separated into two emission bands by the quenching-resolved fluorescence method. One emission band was given as a fraction with the Stern-Volmer quenching constant, 44:9 Â 10 À3 M À1 , against the fluorescence quenching by KI, and it showed an emission maximum intensity at 341 nm. The fluorescence quenching constant of the other band was 1:58 Â 10 À3 M À1 , and the maximum wavelength was found at 337 nm. These separated emissions were due to the fluorescence of Trp54 and Trp9 of BGTI. The quenching resolved-fluorescence spectrum was effectively applied to the precise description of the polar circumstances surrounding the Trp residues in the unfolding intermediate state of BGTI. The results suggested that the molten globule-like state of BGTI adopted such a peculiar conformation that the helix domain including Trp9 was packed more densely while the other loop domain partially unfolded.
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The indole moiety, which is the fluorescent side chain of the tryptophan residue, exhibits a specific photophysical property. In the excited singlet state ascribed to 1 L a by excitation at about 295 nm, the dipole moment of the indole moiety is enormously increased and the resulting dipole-dipole interaction with the surrounding polar molecules lowers the energy level of fluorescence emitting state. In non-polar circumstances, the fluorescence of tryptophan is emitted from the 1 L b state, the energy of which level is just below that of 1 L a . Therefore, the protein with tryptophan residue surrounded by more polar circumstances gives the maximum at the longer wavelength side. Because of this specific property, the tryptophan residue is an excellent reporter of conformation change in proteins. Indeed, fluorescence spectroscopy of a protein through the tryptophan residue has provided essential information on protein structure, dynamics, and function by the advanced time-resolved technique and photo-selection rules.
1) The higher spectroscopic sensitivity and time resolution power of fluorescence methods can detect emission even from a single molecule and resolve fast motions extending to 10 À8 to 10 À12 s. This competence of fluorescence spectroscopy has great advantages for the conformation and dynamic characterization of the protein folding/ unfolding intermediate state, which is intrinsically in disorder, but the fluorescence spectroscopic study of a protein through the tryptophan residue has limits and restrictions. Many proteins contain more than one tryptophan residue. In such a case, it is difficult to distinguish the fluorescent properties of the individual tryptophan residues included in a protein. In order to overcome this limitation, replacement of specified tryptophan residue by site-directed mutagenesis is generally used, but the amino acid replacement method sometimes has serious effects on the conformation around the remaining tryptophan, depending on the location of the tryptophan residue replaced. Furthermore, the amino acid replacement method is a timeconsuming task. Therefore, it is desirable to develop a method to investigate the individuality of the tryptophan residues in multi-tryptophan-containing proteins. Nishimoto et al. succeeded in describing interesting conformational changes and molecular dynamics around Trp-62 and Trp-108 of hen egg-white lysozyme by a combination of quenching resolved fluorescence with site-directed mutagenesis. 2, 3) The quenching resolved fluorescence method used in their work was based on the Sterm-Volmer equation. Tryptophan residue exposed to the protein surface allows the easier approach of quenchers such as acrylamide and KI to quench tryptophyl fluorescence. Thus exposed tryptophan can be distinguished with a buried one by analyzing the quenching efficiency of the quencher.
Trypsin inhibitor from bitter gourd (BGTI) contains two tryptophan residues, at positions, 9 and 54. The fluorescence maximum of BGTI is at 339 nm and the spectral line shape holds greater symmetry. This suggests that two tryptophan residues are in similar polar circumstances, and it is difficult to discriminate them in the ordinary way. In the present study, we separated these two tryptophan residues by the quenching resolved fluorescence technique and the results compared with the fluorescence spectroscopic properties of W9F and W54F, in which Trp9 and Trp54 are replaced with phenylalanine residues. The validity of the quenching resolved fluorescence spectrum was examined, and the results were applied to an investigation of the unfolding of BGTI.
The three-dimensional structure of BGTI has been determined at very high resolution, and its structure has been characterized as a tightly packed domain constituted of two -helices and a loosely packed loop domain. Tryptophan residues, Trp9 and Trp54, are located in the densely packed domain and loop domain, respectively (Fig. 1) . Because of this exquisite arrangement of tryptophan residues, BGTI is the interesting subject in investigating the characteristic conformation and dynamics of the protein folding/unfolding intermediate through fluorescence spectroscopy. The frame structure of BGTI is very similar to that of chymotrypsin inhibitor 2, which has provided interesting information on the protein folding mechanism.
4) Correspondingly, we have reported that the folding/unfolding intermediate state of BGTI locally retained a more densely packed structure using mutant BGTI. 5) In the present study, the peculiar conformation and dynamics of the unfolding intermediate state of BGTI were determined by establishing the quenching-resolved fluorescence properties of BGTI.
Materials and Methods
Materials. Seeds of bitter gourd (Momordica charantia) were purchased from Nakahara (Fukuoka, Japan). Restriction enzymes and DNA modifying enzymes were from MBI Fermentas (Hanover, MD) and Toyobo (Osaka, Japan) respectively. Thermo sequenase cycle sequencing kits containing 7-deaza-dGTP were from GE Healthcare UK (Buckinghamshire, UK). A chameleon double-standard sitedirected mutagenesis kit was from Strategene (La Jolla, CA). An expression plasmid, pET-16b, was from Novagen (Madison, WI). Escherichia coli strains JM109 and Xl1-blue were used as host cells in cloning and mutagenesis, and strain BL21 (DE3) was used for host cells in producing recombinant BGTI and its mutant proteins. All other common chemicals and reagents were purchased at the highest purity available and were used without further purification.
Purification of BGTI. Crude protein including BGTI was extracted from milled and grained seeds of bitter gourd. After precipitation in saturated ammonium sulfate, the crude BGTI was separated and purified by cation-exchange chromatography using HiTrap SP and Mono S columns (GE Healthcare UK). The purified BGTI, the purity of which was confirmed by SDS-PAGE, was dialyzed against 50 mM Tris-HCl buffer, pH 7.5, and stored at À80 C until use. The methods for the expression and purification of mutant BGTI are described in reference 5. The genes encoding the mutant BGTI were expressed in E. coli strain BL21 (DE3) using expression plasmid pET-16b. Mutant BGTIs were purified from extracts of the cells by a combination of HiTrap Chelating column (GE Healthcare UK) and ion exchange column chromatography by the Biologic DuoFlow chromatography system (BioRad, Hercules, CA). First, mutant BGTIs were separated from other proteins with a His-tag trap column, which was prepared by conjugating a HiTrap Chelating column with Ni 2þ . After desalting and condensation, the His-tag was removed by incubating BGTI with Factor Xa for 12 h. In order to remove the His-tag and undigested BGTI, the sample solution was applied to the His-tag trap column again. The eluted sample was purified by cation exchange chromatography using a HiPrep 16/10 CM FF column (GE Healthcare UK), after desalting. The purities of the mutant BGTI were confirmed by HPLC on YMC-Pack Diol-60 (Kyoto, Japan) and SDS-PAGE using 15% polyacrylamide gel. The concentrations of BGTI and its mutants were determined by the spectrophotometric method.
The purified BGTI and its mutants, W54F-BGTI and W9F-BGTI, were prepared in 20 mM Tris-HCl buffer, pH 7.8, for unfolding experiments. Small aliquots of the sample solution were added to reaction mixtures containing the desired concentrations of ganidine hydrochloride (Gdn). These protein solutions were incubated at 25 C for 5 h to attain unfolding equilibrium under conditions including various concentrations of Gdn. Under these conditions, no further changes in any f the experimental parameters used here, such as fluorescence spectra and decay kinetics, were recognized after incubation.
Steady-state and time-resolved fluorescence measurements. Steadystate fluorescence measurements were performed on a Hitachi 850 fluorescence spectrophotometer (Tokyo). The excitation and emission spectra were strictly corrected for the excitation and detection system. The effects of undesired stray light were removed by subtraction methods. Steady-state fluorescence anisotropy was measured using the same instrument. After measurement of parallel (I vv ) and perpendicular (I vh ) components against vertical excitation, fluorescence anisotropy (r) was calculated by the following equation:
where G is the grating factor decided by the intensity ratio of the vertical component to the horizontal one against horizontal excitation. Time-resolved fluorescence and fluorescence anisotropy were measured by the sub-pico second laser based time-correlated single photon counting (TCSPC) method. The excitation pulse (295 nm) was separated from a combination of sub-picosecond Ti-Sapphire laser (Tsunami, Spectra-Physics, Mountain View, CA), pulse picker with second harmonic generator (model 3980, Spectra-Physics), and third harmonic generator (GWU, Spectra-Physics). The repetition rate was 800 kHz, and the full width at half maximum (FWHM) of the excitation pulse obtained was 100 fs. The fluorescence emission pulse was detected with a multi-channel plate type photomultiplier (3809U-50, Hamamatsu Photonics, Shizuoka, Japan). The output signals of a time-to-amplitude convertor (TAC 457, Ortec, Oak Ridge, TN) were accumulated in 2,048 channels in a multi-channel analyzer (Maestro-32, Ortec). The channel width was 11 ps/ch. The details of the apparatus and procedure are described in a previous report. 6) The fluorescence decay kinetics of BGTI were described by a linear combination of exponentials:
where i is the fluorescence decay time of the i-th component and i is the corresponding pre-exponential factor, and i and i were determined by the iterative convolution and non-linear curve fitting methods. The adequacy of curve-fitting was judged by residual plots and statistic parameters, such as the serial variance ratio (SVR) and the sigma value (). CD spectrum measurement. The CD spectrum of BGTI and its mutant were recorded on a J-720 spectropolarimeter (Jasco, Tokyo). The sample solution of BGTI was buffered with 20 mM Tris-HCl buffer, pH 7.8. The protein concentration used for the CD spectrum was adjusted to 0.1 mg/ml. A CD cuvette with a 1-mm optical-path length was used for measurements in the far-UV region.
Quenching-resolved fluorescence spectrum. The quenchingresolved fluorescence spectrum of BGTI was obtained using a modification of the Stern-Volmer equation:
where F and F 0 are the fluorescence intensities in the presence and absence of the quencher molecule (Q), and K SV i and f i are the i-th Stern-Volmer constant and the corresponding fraction of the steadystate fluorescence intensity. The fluorescence spectra were precisely measured in the presence of the desired concentrations of KI. The fluorescence intensity, sampled at 2-nm intervals, was plotted based on eq. 3, and parameters K SV i and f i were determined by simultaneous global analysis. The quenching-resolved fluorescence spectrum was obtained by assigning the fluorescence intensity according to the f i at each wavelength.
Results
Quenching-resolved fluorescence spectrum As shown in Fig. 2 , the fluorescence spectrum of BGTI appeared as a single band with the center at 339 nm in 20-mM Tris-HCl buffer solution (pH 7.2). Since BGTI contains two tryptophan residues, Trp9 and Trp54, in the vicinity, adjacent to the hydrophobic core and near the loop structure respectively, the fluorescence of BGTI must be composed of the emissions of the two Trps, which exhibited slightly different spectrum distributions. The fluorescence of BGTI decreased in intensity without shifting of the emission maximum wavelength in the presence of 3 M of Gdn, and the spectrum eventually shifted in maximum wavelength to 355 nm, accompanying a reduction in intensity in the buffer containing 6 M Gdn.
The inset of Fig. 3 shows fluorescence spectral changes in BGTI under quenching by KI. While the fluorescence intensity fell with increases in the concentration of KI, the fluorescence maximum wavelength shifted to the blue side, because fluorescence was quenched more effectively on the longer wavelength side. The global curve-fitting results at various wavelengths deciding the Stern-Volmer quenching constant, K SV , and the corresponding fluorescence emission fraction, f , are shown in Fig. 3 . The fitting adequacy, chi-square, and the correlation were 5 Â 10 À5 and 1.00 respectively. Figure 4 shows the quenching-resolved fluorescence spectrum of BGTI obtained by allocating the steady-state fluorescence intensity at the various wavelengths according to the size of the fraction, f , was seen at 337 nm, while the total fluorescence emission spectrum showed a maximum at 339 nm. The normalized fluorescence band intensities of f 1 and f 2 were 0.67 and 0.33 respectively.
The fluorescence spectra of W9F-and W54F-BGTI showed fluorescence maxima at 342 nm and 336 nm respectively. 5) Considering that the bandpath of the fluorescence spectrophotometer used was 2 nm, those values are consistent with those of components f 1 and f 2 in the quenching-resolved fluorescence spectrum of BGTI. The fluorescence quantum yields of W9F and W54F mutant of BGTI estimated using N-acetyl-Ltryptophanamide as fluorescence standard were 0.1 and 0.005 respectively, whereas that of BGTI was larger, estimated to be 0.14.
Fluorescence intensity decay
The fluorescence decay function is given by determining parameters such as the number of components, i, decay time, i , and the corresponding amplitude i in a linear combination of the exponential function. The fluorescence decay parameters of BGTI, W9F-BGTI, and W54F-BGTI are summarized in Table 1 . The fluorescence decay kinetics of BGTI were described by the triple exponential, the components of which were characterized by decay times of 5.31, 0.40, and 0.05 ns. On the other hand, the fluorescence decay kinetics of the mutant BGTI showed the best fit to the double exponentials. Although the number of decay components of BGTI was expected to be 4, the shorter decay time of W9F-BGTI and the longer one of W9F-BGTI were not resolved in the decay function of BGTI. It should be noted that the longer decay time of W9F-BGTI was longer than the longest decay time of BGTI. The average lifetime of W54F-BGTI, defined as av ¼ AE i i , was extremely short, and the shorter decay time was estimated to be shorter than the shortest one of BGTI. As clearly shown in Table 1 , the longest and shortest decay times were contributions of Trp54 and Trp9 respectively. In order to determine the individual spectroscopic properties of the tryptophan residue in the mutant and wild-type BGTI, the radiative ( r ) and non-radiative ( nr ) lifetimes were estimated by the fluorescence quantum yield () and decay parameters based on the equation ¼ av = r and 1= av ¼ 1= r þ 1= nr . These fluorescence parameters are also summarized in Table 1 . The radiative transition rate of Trp9 was 3.5 times faster than that of Trp54. As shown by the larger k nr , Trp9 interacts with surrounding amino acids such as Lys6 and Glu27. Their amino and carboxyl groups are dominant quenchers for tryptophyl fluorescence through the proton transfer and electron transfer mechanism. Figure 5A shows the equilibratory unfolding profile of BGTI as revealed by changes in fluorescence intensity and maximum wavelength. The fluorescence intensity started to decrease at 1 M of Gdn, and reached an almost constant value at Gdn concentrations higher than 5 M. On the other hand, the fluorescence maximum wavelength was unchanged until 4 M of Gdn. These results suggest that the large conformation change that the tryptophan residues were exposed at the protein surface was initiated in the presence of Gdn at higher than 4 M. A conformational change that results in a decrease in tryptophyl fluorescence intensity should be induced in the presence of 3-4 M of Gdn. The unfolding profile, as monitored by the ellipticity of the CD spectrum, is shown in Fig. 5B . The CD spectrum of BGTI did not show the usual double minimum, but almost a single peak at 205 nm, which is attributable to the 0 -À transition (data not shown). When the ellipticities at 222 nm were plotted against the Gdn concentration, they were constant up to 3 M of Gdn, and then decreased to show a constant value at 6 M. The steady-state fluorescence anisotropy measured at 340 nm (Fig. 5B) increased and then decreased increases in the concentration of Gdn, and showed a maximum value at 3 M.
Protein unfolding
The fluorescence anisotropy depends on the viscosity of the solution. Therefore, much attention should be paid to interpretation of the results of fluorescence anisotropy. However, it is reasonable to conclude that the decrease in the fluorescence anisotropy precedes the decrease in ellipticity in CD, and the internal motion of peptide segments, including tryptophan residues, which is a controlling factor in fluorescence anisotropy, is suppressed most in the presence of about 3 M of Gdn.
The fluorescence spectra of BGTI under quenching by KI were measured in buffer solution including 2, 4, 6, and 8 M of Gdn (data not shown). The fluorescence intensities at the various wavelengths were not necessarily quenched uniformly. Quenching efficiencies were higher on the longer wavelength side. This tendency was especially pronounced solutions of 2 and 4 M of Gdn, and therefore the fluorescence spectrum of BGTI equilibrated in this concentration region of Gdn showed a blue-shifted line shape in the presence of higher concentrations of KI. The precision of global analysis of the fluorescence intensities at various wavelengths covering the full spectral region against the KI concentration was so high that the fluorescence quenching of BGTI was well described with two Stern-Volmer constants and the corresponding fractions at each wavelength. The quenching-resolved fluorescence spectrum was obtained by allocating the steady-state fluorescence intensity according to the fraction size at each wavelength. Figure 6 shows the quenching-resolved fluorescence spectra of BGTI equilibrated with 0, 2, 4, 6, and 8 M of Gdn. As shown in Fig. 4 , the fluorescence spectrum of BGTI in the absence of Gdn was resolved into two sub-bands with maxima at 341 nm ( f 1 ) and 337 nm ( f 2 ). The f 2 band shifted the maximum wavelength to the blue side a little with keeping the f 1 maximum constant at 2 M of Gdn. In the solution including 4 M of Gdn, in which the higher fluorescence anisotropy value was observed, the f 1 band shifted to 349 nm and the f 2 band reversely shifted to 330 nm. Both of these bands shifted to the red side at 6 M, eventually reaching 355 nm at 8 M of Gdn. The SternVolmer constants obtained are summarized in Table 2 . The quenching constant, K SV 1 , for the f 1 band was estimated to be extraordinarily large, and was always larger than the K SV 2 for the f 2 band. Thus the f 1 and f 2 bands corresponded to the fluorescence spectra of Trp54 and Trp9 respectively. We have found that these tryptophan residues in W9F-and W54F-BGTI responded to Gdn similarly to the f 1 and f 2 bands.
5) The exclusive red shifts of the f 1 and the bi-directional spectral shift of the f 2 band suggest that BGTI was in an 
Discussion
The fluorescence spectrum of BGTI was separated into two bands by the quenching-resolved technique based on a modification of the Stern-Volmer equation. The separated fluorescence bands gave maximum intensities at 341 nm and 337 nm, and their corresponding quenching constants by KI were K SV ¼ 44:9 Â 10 À3 M À1 and 1:58 Â 10 À3 M À1 respectively. These bands are presumably to be attributed to the fluorescence of Trp54 and Trp9, because their peak wavelengths were coincident with the spectrum of mutant BGTI. The crystallographic structure of BGTI confirms this conclusion. Trp9 is located in a more densely-packed region, and hence should give a smaller quenching constant. The coincidence of the quenching-resolved fluorescence band of BGTI with mutant BGTI suggests that the polar circumstances of the two tryptophan residues are not much changed by the mutations. The present results suggest that the quenching-resolved fluorescence spectrum is a potent method of separating the tryptophan residue arranged at similar polar circumstances to specify individual fluorescence spectroscopic properties in a multi-tryptophan containing protein without amino acid replacement. However, inconsistencies in the fluorescence decay kinetics of BGTI indicate that the amino acid replacement has some effect on the local conformation around Trp9 and Trp54. The shorter decay time of the fluorescence of W54F-BGTI was prolonged and longer decay time of W9F-BGTI was shortened in the BGTI. Trp9 at the position adjacent to the hydrophobic core should enhance interaction with the surrounding Lys and/or Glu by replacement of Trp54 with Phe. On the other hand, replacement of Trp9 might modify the conformation of the loop structure of BGTI.
The fraction intensity ratio of two emission bands in the quenching-resolved spectrum was 2, and the fluorescence quantum yield ratio of Trp54 against that of Trp9 was estimated to be 20. This suggests that the emission contribution of Trp9 is larger to the total fluorescence of BGTI than that expected from the ratio of the quantum yield. Indeed, the radiative transition rate of Trp9 was larger than that of Trp54, as shown in Table 2 , and therefore the absorption efficiency was higher. Probably this discrepancy is to be explained by the energy transfer between Trp9 and Trp54. Visser et al. proposed energy migration between Trp residues. 8) According to the crystallographic structure, the distance between Trp9 and Trp54 is about 13 Å , which corresponds to the usual critical distance of Trp-Trp energy transfer. Therefore, an energy transfer or migration between Trp9 and Trp54 is probable. Since the fast fluorescence quenching rate due to KI occurred preferentially to the energy transfer, the emission fraction of Trp9 is estimated to be higher.
The fluorescence quenching-resolved spectrum is expected to be useful in investigating the local conformation change site by site in a protein molecule, and has been examined in protein folding/unfolding studies. Three promising models are proposed to elucidate the protein folding mechanism. In the framework model, the structural frame constituting the secondary structures is formed first, and it is folded compactly onto the native structure.
9) Nucleation-condensation suggests the creation of a nucleus site promoting ordering of the polypeptide elements by analogy with the crystal growth of various molecules.
10) The landscape model proposes that protein folding is a convergent process of many randomly populating conformation states to some specific conformation states following funnel-like potentials. 11) To inspect the validity of these models, the conformational and dynamic properties exhibited by the protein folding/unfolding intermediate state must be clarified. The MG state is recognized as the general protein folding intermediate state. The fundamental properties of the MG state, that the secondary structure is retained but the tertiary structure is reduced or relaxed, appears to confirm the framework model, but molten globule-like state or an other sub-state such as a tryptophan immobile state or a pre-molten globule state provide evidence for the nucleation-condensation and landscape models. The results obtained here consistently indicate that BGTI unfolds through a specific conformation state. The secondary structure was strictly retained, and no fluorescence spectral shift to the red side of BGTI was found until the Gdn concentration was higher than 4 M. Furthermore, one fluorescence band ( f 1 ) in the quenching-resolved fluorescence spectrum, presumably attributable to Trp54, showed a red shift, and the rotational freedom of the same tryptophan residue increased to a Gdn concentration range of 2-4 M. These features of the specific conformation state are consistent with the fundamental properties of the MG state. But it should be noted that the fluorescence band ( f 2 ) with a smaller quenching constant and Trp9 in the W54F-BGTI shifted in maximum wavelength to 330 nm when the Gdn concentration increased from 0 to 4 M. At the same time, the rotational motion of Trp9 was restricted to the same Gdn concentration range. This suggests that a specific conformation state such that the packing of Trp54 is relaxed, and contrarily, the amino acid residues surrounding Trp9 are more compactly packed as the concentration of Gdn increases to 6 M. No such partially structured or partially unfolded intermediate state of the protein has been established, although a tryptophan immobile state involved in the unfolding of creatin kinase was reported through special analytical methods for the fluorescence spectrum. The protein folding/ unfolding intermediate state, the MG state, is stabilized through interaction between -helices. 12) Chymotrypsin inhibitor 2, the native structure of which was very similar to BGTI, created a nucleus site in the -helices domain, controling the subsequent protein folding process. 4) Considering these experimental facts, the heterogeneous packing conformation of BGTI observed here is interesting for elucidation the protein folding/unfolding mechanism, because Trp9 is located in the adjacent part of the -helices, and restriction of the rotational motion and the blue shift of the fluorescence spectrum of this tryptophan residue can result from specific cohesive interactions between the surrounding -helices, which stabilize the BGTI structure against the destructive fluctuation of the loosely packed domain in the protein unfolding process.
